|
1
|
Subramanian J and Govindan R: Lung cancer
in never smokers: a review. J Clin Oncol. 25:561–570. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu C, Onn A, Vaporciyan AA, et al: Cancer
of the Lung. Holland-Frei Cancer Medicine. 8th edition. People’s
Medical Publishing House; 2010
|
|
3
|
Scagliotti GV and Selvaggi G: New date
integrating multitargeted anifolates into treatment of first-line
and relapsed non-small-cell lung cancer. Clin Lung Cancer. 9(Suppl
3): S122–S128. 2008. View Article : Google Scholar
|
|
4
|
Lv YT, Du PJ, Wang QY, Tan Y, Sun ZB, Su
ZL and Kang CM: A novel approach to cloning and expression of human
thymidylate synthase. Asian Pac J Cancer Prev. 14:7523–7527. 2013.
View Article : Google Scholar
|
|
5
|
Li WJ, Jiang H, Fang XJ, Ye HL, Liu MH,
Liu YW, Chen Q, Zhang L, Zhang JY, Yuan CL and Zhang QY:
Polymorphisms in thymidylate synthase and reduced folate carrier
(SLC19A1) genes predict survival outcome in advanced non-small cell
lung cancer patients treated with pemetrexed-based chemotherapy.
Oncol Lett. 5:1165–1170. 2013.PubMed/NCBI
|
|
6
|
Bai C, Shi H, Liu D, Zhu T, Hu Z and Li Q:
Gemcitabine plus oxaliplatin for the treatment of leptomeningeal
metastases of non-smell cell lung cancer: A case report and review
of the literature. Oncol Lett. 5:1559–1561. 2013.PubMed/NCBI
|
|
7
|
Odin E, Wettergren Y, Nilsson S, Willén R,
Carlsson G, Spears CP, Larsson L and Gustavsson B: Altered gene
expression of folate enzymes in adjacent mucosa is associated with
outcome of colorectal cancer patients. Clin Cancer Res.
9:6012–6019. 2003.PubMed/NCBI
|
|
8
|
Nishimura R, Nagao K, Miyayama H, Matsuda
M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higuchi A, Satoh A,
et al: Thymidylate synthase levels as a therapeutic and prognostic
predictor in breast cancer. Anticancer Res. 19:5621–5626. 1999.
|
|
9
|
Shiga H, Heath EI, Rasmussen AA, Trock B,
Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M and
Cullen KJ: Prognostic value of p53, glutathione S-transferase pi,
and thymidylate synthase for neoadjuvant cisplatin-based
chemotherapy in head and neck cancer. Clin Cancer Res. 5:4097–4104.
1999.
|
|
10
|
Takamura M, Nio Y, Yamasawa K, Dong M,
Yamaguchi K and Itakura M: Implication of thymidylate synthase in
the outcome of patients with invasive ductal carcinoma of the
pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil
or its derivatives. Anticancer Drugs. 13:75–85. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shintani Y, Ohta M, Hirabayashi H, Tanaka
H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S and Matsuda H:
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA
levels in tumor tissues and the efficacy of 5-fluorouracil in
patients with non-small-cell lung cancer. Lung Cancer. 45:189–196.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ceppi P, Volante M, Saviozzi S, Rapa I,
Novello S, Cambieri A, Lo Iacono M, Cappia S, Papotti M and
Scagliotti GV: Squamous cell carcinoma of the lung compared with
other histotypes shows higher messenger RNA and protein levels for
thymidylate synthase. Cancer. 107:1589–1596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morganti M, Ciantelli M, Giglioni B, et
al: Relationships between promoter polymorphisms in the thymidylate
synthase gene and mRNA levels in colorectal cancers. Eur J Cancer.
41:2176–2183. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SW, Chen TJ, Lin LC, et al:
Overexpression of thymidylate synthetase confers an independent
prognostic indicator in nasopharyngeal carcinoma. J Exp Mol Pathol.
95:83–90. 2013. View Article : Google Scholar
|
|
15
|
Popat S, Matakidou A and Houlston RS:
Thymidylate synthase expression and prognosis in colorectal cancer:
a systematic review and meta-analysis. J Clin Oncol. 22:529–536.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ: ABI Prism 7700 Sequence
Detection System User Bulletin. Relative Quantitation of Gene
Expression. http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf.
Accessed October 20, 2013
|
|
17
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
18
|
Zhang Y, Meng X, Zeng H, Guan Y, Zhang Q,
Guo S, Liu X and Guo Q: Serum vascular endothelial growth factor-C
levels: A possible diagnostic marker for lymph node metastasis in
patients with primary non-small cell lung cancer. Oncol Lett.
6:545–549. 2013.PubMed/NCBI
|
|
19
|
Collins LG, Haines C, Perkel R and Enck
RE: Lung cancer: diagnosis and management. Am Fam Physician.
75:56–63. 2007.PubMed/NCBI
|
|
20
|
Liao F, Yang Z, Lu X, Guo X and Dong W:
Sinomenine sensitizes gastric cancer cells to 5-fluorouracil in
vitro and in vivo. Oncol Lett. 6:1604–1610. 2013.PubMed/NCBI
|
|
21
|
Kumamoto K, Kuwabara K, Tajima Y, Amano K,
Hatano S, Ohsawa T, Okada N, Ishibashi K, Hage N and Ishida H:
Thymidylate synthase and thymidine phosphorylase mRNA expression in
primary lesions using laser capture microdissection is useful for
prediction of the efficacy of FOLFOX treatment in colorectal cancer
patients with liver metastasis. Oncol Lett. 3:983–989.
2012.PubMed/NCBI
|
|
22
|
Mizutani Y, Wada H, Yoshida O, Fukushima
M, Bonavida B, Kawauchi A and Miki T: Prognostic significance of a
combination of thymidylate synthase and dihydropyrimidine
dehydrogenase activities in grades 1 and 2 superficial bladder
cancer. Oncol Rep. 9:289–292. 2002.PubMed/NCBI
|
|
23
|
da Silva Nogueira J, de Lima Marson FA and
Silvia Bertuzzo C: Theymidylate synthase gene (TYMS) polymorphisms
in sporadic and hereditary breast cancer. BMC Res Notes. 5:6762012.
View Article : Google Scholar
|
|
24
|
Ceppi P, Rapa I, Lo Iacono M, Righi L,
Giorcelli J, Pautasso M, Billè A, Ardissone F, Papotti M and
Scagliotti GV: Expression and pharmacological inhibition of
thymidylate synthase and Src kinase in nonsmall cell lung cancer.
Int J Cancer. 130:1777–1786. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takezawa K, Okamoto I, Tsukioka S, Uchida
J, Kiniwa M, Fukuoka M and Nakagawa K: Identification of
thymidylate synthase as a potential therapeutic target for lung
cancer. Br J Cancer. 103:354–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang M, Fan WF, Pu XL, Liu FY, Meng LJ and
Wang J: Significance of thymidylate synthase expression for
resistance to pemetrexed in pulmonary adenocarcinoma. Oncol Lett.
7:227–232. 2014.
|
|
27
|
Hashimoto H, Ozeki Y, Sato M, Obara K,
Matsutani N, Nakagishi Y, Ogata T and Maehara T: Significance of
thymidylate synthase gene expression level in patients with
adenocarcinoma of the lung. Cancer. 106:1595–1601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shimokawa H, Uramoto H, Onitsuka T, Iwata
T, Nakagawa M, Ono K and Hanagiri T: TS expression predicts
postoperative recurrence in adenocarcinoma of the lung. Lung
Cancer. 72:360–364. 2011. View Article : Google Scholar
|
|
29
|
Nakagawa T, Tanaka F, Otake Y, Yanagihara
K, Miyahara R, Matsuoka K, Takata T, Yamada T, Fukushima M and Wada
H: Prognostic value of thymidylate synthase expression in patients
with p-stage I adenocarcinoma of the lung. Lung Cancer. 35:165–170.
2002. View Article : Google Scholar : PubMed/NCBI
|
